PATH receives $5 million to make vaccines more heat stable

One of the biggest problems with vaccines is that they usually need refrigeration. PATH has long worked on this problem, called the cold chain, on a variety of fronts.

Luke Timmerman of Xconomy has a good description of this latest project and why it matters:

One of the big ideas PATH is pursuing to make vaccines more useful just got a strong vote of confidence. PATH is announcing today it has secured a $5.2 million contract from the U.S. government to develop flu vaccines that can remain effective for years when they are stashed away in a stockpile, in case officials ever need it to perform mass vaccinations during a global flu pandemic.

Share.

About Author

Tom Paulson

Tom Paulson is founder and lead journalist at Humanosphere. Prior to operating this online news site, he reported on science,  medicine, health policy, aid and development for the Seattle Post-Intelligencer. Contact him at tom[at]humanosphere.org, follow him on Twitter @tompaulson and/or send a comment below.